207 related articles for article (PubMed ID: 26588988)
1. Down-regulation of LATS kinases alters p53 to promote cell migration.
Furth N; Bossel Ben-Moshe N; Pozniak Y; Porat Z; Geiger T; Domany E; Aylon Y; Oren M
Genes Dev; 2015 Nov; 29(22):2325-30. PubMed ID: 26588988
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
Yao F; Liu H; Li Z; Zhong C; Fang W
Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
[TBL] [Abstract][Full Text] [Related]
4. LATS tumor suppressor: a new governor of cellular homeostasis.
Visser S; Yang X
Cell Cycle; 2010 Oct; 9(19):3892-903. PubMed ID: 20935475
[TBL] [Abstract][Full Text] [Related]
5. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Fer induces ROS levels accompanied by ATM and p53 activation in colon carcinoma cells.
Makovski A; Yaffe E; Shpungin S; Nir U
Cell Signal; 2012 Jul; 24(7):1369-74. PubMed ID: 22434045
[TBL] [Abstract][Full Text] [Related]
7. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract][Full Text] [Related]
8. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.
Furth N; Aylon Y
Cell Death Differ; 2017 Sep; 24(9):1488-1501. PubMed ID: 28644436
[TBL] [Abstract][Full Text] [Related]
9. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.
Aylon Y; Ofir-Rosenfeld Y; Yabuta N; Lapi E; Nojima H; Lu X; Oren M
Genes Dev; 2010 Nov; 24(21):2420-9. PubMed ID: 21041410
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
11. Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.
Visser S; Yang X
Gene; 2010 Jan; 449(1-2):22-9. PubMed ID: 19799973
[TBL] [Abstract][Full Text] [Related]
12. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1.
Chan EH; Nousiainen M; Chalamalasetty RB; Schäfer A; Nigg EA; Silljé HH
Oncogene; 2005 Mar; 24(12):2076-86. PubMed ID: 15688006
[TBL] [Abstract][Full Text] [Related]
13. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L).
Ke H; Pei J; Ni Z; Xia H; Qi H; Woods T; Kelekar A; Tao W
Exp Cell Res; 2004 Aug; 298(2):329-38. PubMed ID: 15265683
[TBL] [Abstract][Full Text] [Related]
14. TGFbeta-1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFbeta-receptor I signalling.
Wiegman EM; Blaese MA; Loeffler H; Coppes RP; Rodemann HP
Radiother Oncol; 2007 Jun; 83(3):289-95. PubMed ID: 17560675
[TBL] [Abstract][Full Text] [Related]
15. MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor.
Deng X; Ye D; Hua K; Song H; Luo Q; Munankarmy A; Liu D; Zhou B; Zheng W; Zhou X; Ji C; Wang X; Yu Y; Fang L
Cell Death Dis; 2021 Aug; 12(9):810. PubMed ID: 34446703
[TBL] [Abstract][Full Text] [Related]
16. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
St-Germain ME; Gagnon V; Parent S; Asselin E
Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
[TBL] [Abstract][Full Text] [Related]
17. Induction of genetic instability by gain-of-function p53 cancer mutants.
Xu Y
Oncogene; 2008 Jun; 27(25):3501-7. PubMed ID: 18223686
[TBL] [Abstract][Full Text] [Related]
18. LATS2 is a tumor suppressor gene of malignant mesothelioma.
Murakami H; Mizuno T; Taniguchi T; Fujii M; Ishiguro F; Fukui T; Akatsuka S; Horio Y; Hida T; Kondo Y; Toyokuni S; Osada H; Sekido Y
Cancer Res; 2011 Feb; 71(3):873-83. PubMed ID: 21245096
[TBL] [Abstract][Full Text] [Related]
19. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
[TBL] [Abstract][Full Text] [Related]
20. [Interaction between ATM and radiation-activated phosphorylation of P53 and P21].
Luo JL; Cao JP; Zhu W; Feng S; Sheng FJ; Zhu CY; Zheng SY
Ai Zheng; 2005 Sep; 24(9):1059-63. PubMed ID: 16159425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
